DIVI'S LABORATORIES LIMITED
DIVISLAB.NSLoading price...
Overview
Previous Close9,438.5
Open9,370
Ask0
Bid0
Day's Range9,310.5 - 9,415
52 Week Range5,636.5 - 9,615
PE Ratio(TTM)84.42
Market Cap₹2,47,470Cr
Volume₹5,16,756
Avg. Volume₹4,57,461
Face Value--
Dividend Yield0.32%
Analyst Consensus
Rating Breakdown (29 analysts)
Strong Buy: 4Buy: 10Hold: 6Sell: 3Strong Sell: 6
Performance
ABSCAGR
| YTD | 1 Month | 3 Months | 1 Year | 2 Years | 5 Years | 10 Years | |
|---|---|---|---|---|---|---|---|
| No results to display | |||||||
Profit/Loss
| PARTICULARS | ||||||
|---|---|---|---|---|---|---|
| No results to display | ||||||
Company Profile
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
HQ Location: Hyderabad, India
Website: https://www.divislabs.com
CEO & Whole-Time Director: Dr. Kiran Satchandra Divi B. Pharm., M.Pharm
Employees: 11,565
About Company:
Divi's Laboratories Limited engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally. The company also undertakes custom synthesis contract manufacturing services of APIs and intermediates; and supplies a range of carotenoids, such as astaxanthin, beta-carotene, lycopene, canthaxanthin, apocarotenal, and vitamins used in the food, beverage, dietary supplement, pet food, and feed industries. It also exports its products. The company was formerly known as Divi's Research Center and changed its name to Divi's Laboratories Limited in 1994. Divi's Laboratories Limited was incorporated in 1990 and is based in Hyderabad, India.